Profile | GDS4284 / 219581_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 757.802 | 70 |
GSM687648 | Patient 402 control | 1004.99 | 74 |
GSM687653 | Patient 403 control | 899.695 | 73 |
GSM687658 | Patient 404 control | 776.897 | 70 |
GSM687663 | Patient 411 control | 864.647 | 72 |
GSM687668 | Patient 422 control | 840.305 | 71 |
GSM687673 | Patient 424 control | 875.966 | 72 |
GSM687678 | Patient 425 control | 921.557 | 72 |
GSM687683 | Patient 427 control | 845.936 | 71 |
GSM687688 | Patient 428 control | 478.361 | 63 |
GSM687695 | Patient 441 control | 566.892 | 64 |
GSM687699 | Patient 443 control | 852.137 | 71 |
GSM687704 | Patient 444 control | 1077.07 | 75 |
GSM687707 | Patient 448 control | 1053.4 | 75 |
GSM687712 | Patient 449 control | 689.829 | 68 |
GSM687719 | Patient 450 control | 1042.23 | 74 |
GSM687724 | Patient 451 control | 970.286 | 74 |
GSM687728 | Patient 452 control | 704.656 | 69 |
GSM687646 | Patient 401 treated 24h | 975.328 | 73 |
GSM687649 | Patient 402 treated 24h | 952.069 | 73 |
GSM687665 | Patient 411 treated 24h | 926.316 | 73 |
GSM687651 | Patient 402 treated 4 weeks | 891.314 | 72 |
GSM687667 | Patient 411 treated 4 weeks | 1130.2 | 75 |
GSM687670 | Patient 422 treated 24h | 635.921 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 794.126 | 70 |
GSM687654 | Patient 403 treated 24h | 731.43 | 70 |
GSM687675 | Patient 424 treated 24h | 634.692 | 67 |
GSM687685 | Patient 427 treated 24h | 1057.3 | 75 |
GSM687656 | Patient 403 treated 4 weeks | 935.894 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 701.133 | 68 |
GSM687687 | Patient 427 treated 4 weeks | 937.973 | 73 |
GSM687692 | Patient 428 treated 4h | 840.467 | 71 |
GSM687716 | Patient 449 treated 4h | 599.447 | 67 |
GSM687722 | Patient 450 treated 4h | 723.14 | 69 |
GSM687680 | Patient 425 treated 24h | 1153.12 | 76 |
GSM687690 | Patient 428 treated 24h | 441.572 | 63 |
GSM687700 | Patient 443 treated 24h | 641.804 | 65 |
GSM687705 | Patient 444 treated 24h | 980.221 | 74 |
GSM687714 | Patient 449 treated 24h | 761.679 | 70 |
GSM687721 | Patient 450 treated 24h | 583.09 | 65 |
GSM687682 | Patient 425 treated 4 weeks | 891.727 | 72 |
GSM687694 | Patient 428 treated 4 weeks | 862.572 | 71 |
GSM687702 | Patient 443 treated 4 weeks | 679.823 | 67 |
GSM687718 | Patient 449 treated 4 weeks | 501.131 | 64 |
GSM687723 | Patient 450 treated 4 weeks | 801.343 | 71 |
GSM687661 | Patient 404 treated 4h | 487.35 | 63 |
GSM687710 | Patient 448 treated 4h | 987.776 | 75 |
GSM687726 | Patient 451 treated 4h | 964.648 | 73 |
GSM687730 | Patient 452 treated 4h | 718.486 | 66 |
GSM687660 | Patient 404 treated 24h | 424.786 | 61 |
GSM687697 | Patient 441 treated 24h | 426.419 | 59 |
GSM687709 | Patient 448 treated 24h | 842.763 | 72 |
GSM687725 | Patient 451 treated 24h | 1173.82 | 77 |
GSM687729 | Patient 452 treated 24h | 511.843 | 64 |
GSM687727 | Patient 451 treated 4 weeks | 1210.38 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 889.201 | 72 |